Brunham R C
Am J Obstet Gynecol. 1984 Feb 1;148(3):235-40. doi: 10.1016/s0002-9378(84)80061-7.
Recent approaches to determine optimal antimicrobial treatment for acute pelvic inflammatory disease are reviewed. From this review, it is suggested that in future studies a randomized study design, with controls for known factors which influence prognosis, and a uniform objective scoring system for monitoring clinical response be used and long-term evaluation of tubal function be performed. Such studies are urgently needed if optimal therapy for pelvic inflammatory disease is to be defined.
